China Relies On Hospital Drug-Charge Change In Health-Reform Plan
This article was originally published in PharmAsia News
One element of China's new health-care reform package involves a trial policy aimed at ending state-owned hospitals reliance on drug charges for income. Details of the plan have not been made public yet, but the intent is to reduce the tendency of physicians to prescribe expensive drugs rather than cheaper versions to drive up hospital income. Under the reform plan, those funds would be replaced in part by changes in medical insurance designed to reduce costs for the patients. (Click here for more
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.